CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 769 of 1

Non-Antibody Products
Page 769 of 1,288
  • Records 38,401 - 38,450 of 64,374
Name Description Size Catalog #
ML-289 A negative allosteric modulator of mGlu3 (IC50 = 0.66 µM) that displ… 5 mg 15195-5 More Info
ML-290 An RXFP1 agonist (EC50 = 0.094 µM for the human receptor in a cAMP p… 1 mg 21134-1 More Info
ML-290 An RXFP1 agonist (EC50 = 0.094 µM for the human receptor in a cAMP p… 10 mg 21134-10 More Info
ML-290 An RXFP1 agonist (EC50 = 0.094 µM for the human receptor in a cAMP p… 5 mg 21134-5 More Info
ML-291 A novel activator of the apoptotic arm of the UPR, but not the adaptive arm 1 mg 19831-1 More Info
ML-291 A novel activator of the apoptotic arm of the UPR, but not the adaptive arm 10 mg 19831-10 More Info
ML-291 A novel activator of the apoptotic arm of the UPR, but not the adaptive arm 25 mg 19831-25 More Info
ML-291 A novel activator of the apoptotic arm of the UPR, but not the adaptive arm 5 mg 19831-5 More Info
ML-297 A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… 1 mg 14792-1 More Info
ML-297 A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… 10 mg 14792-10 More Info
ML-297 A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… 25 mg 14792-25 More Info
ML-297 A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… 5 mg 14792-5 More Info
ML-298 A selective inhibitor of PLD2 (IC50 = 355 nM); decreases invasive migratio… 1 mg 15349-1 More Info
ML-298 A selective inhibitor of PLD2 (IC50 = 355 nM); decreases invasive migratio… 10 mg 15349-10 More Info
ML-298 A selective inhibitor of PLD2 (IC50 = 355 nM); decreases invasive migratio… 5 mg 15349-5 More Info
ML-299 A dual inhibitor of PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); sel… 1 mg 17632-1 More Info
ML-299 A dual inhibitor of PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); sel… 5 mg 17632-5 More Info
ML-299 A dual inhibitor of PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); sel… 500 µg 17632-500 More Info
ML-311 An inhibitor of Mcl-1 (IC50 = 0.31 µM in a fluorescence polarization… 1 mg 29445-1 More Info
ML-311 An inhibitor of Mcl-1 (IC50 = 0.31 µM in a fluorescence polarization… 10 mg 29445-10 More Info
ML-311 An inhibitor of Mcl-1 (IC50 = 0.31 µM in a fluorescence polarization… 5 mg 29445-5 More Info
ML-314 An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… 1 mg 19550-1 More Info
ML-314 An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… 10 mg 19550-10 More Info
ML-314 An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… 25 mg 19550-25 More Info
ML-314 An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… 5 mg 19550-5 More Info
ML-323 A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… 10 mg 18010-10 More Info
ML-323 A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… 25 mg 18010-25 More Info
ML-323 A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… 5 mg 18010-5 More Info
ML-323 A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… 50 mg 18010-50 More Info
ML-324 A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… 1 mg 17472-1 More Info
ML-324 A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… 10 mg 17472-10 More Info
ML-324 A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… 25 mg 17472-25 More Info
ML-324 A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… 5 mg 17472-5 More Info
ML-329 An inhibitor of the MITF pathway (IC50 = 1.2 µM for TRPM-1 promoter… 1 mg 22481-1 More Info
ML-329 An inhibitor of the MITF pathway (IC50 = 1.2 µM for TRPM-1 promoter… 10 mg 22481-10 More Info
ML-329 An inhibitor of the MITF pathway (IC50 = 1.2 µM for TRPM-1 promoter… 5 mg 22481-5 More Info
ML-334 An inhibitor of the Nrf2-Keap1 protein-protein interaction; binds to the K… 1 mg 31439-1 More Info
ML-334 An inhibitor of the Nrf2-Keap1 protein-protein interaction; binds to the K… 10 mg 31439-10 More Info
ML-334 An inhibitor of the Nrf2-Keap1 protein-protein interaction; binds to the K… 5 mg 31439-5 More Info
ML-335 The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… 1 mg 15196-1 More Info
ML-335 The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… 10 mg 15196-10 More Info
ML-335 The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… 25 mg 15196-25 More Info
ML-335 The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… 5 mg 15196-5 More Info
ML-335 An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… 10 mg 27635-10 More Info
ML-335 An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… 25 mg 27635-25 More Info
ML-335 An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… 5 mg 27635-5 More Info
ML-335 An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… 50 mg 27635-50 More Info
ML-336 A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… 1 mg 9001920-1 More Info
ML-336 A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… 10 mg 9001920-10 More Info
ML-336 A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… 25 mg 9001920-25 More Info
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640

Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com

http://www.caymanchem.com

Facebook

Twitter


Return to Profile

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.